BVSBioventus Inc.

$581M

FY 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$319M+9.3% YoY

Gross Profit

$235M73.6% margin

Operating Income

$26M8.0% margin

Net Income

-$12M-3.8% margin

EPS (Diluted)

$-0.22

Cash Flow

Operating Cash Flow

$45M

Free Cash Flow

$39M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$443M

Total Liabilities

$297M

Stockholders' Equity

$145M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$319M	$292M	+9.3%
Gross Profit	$235M	$200M	+17.5%
Operating Income	$26M	$27M	-5.6%
Net Income	-$12M	-$2M	-644.8%

BVS FY 2018 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena